Sodium (R)-2-(4’-(3-Methyl-4-(((1-Phenylethoxy)Carbonyl)Amino)Isoxazol-5-Yl)-[1,1’-Biphenyl]-4-Yl)Acetate (R)-2-(4’-(3-甲基-4-(((1-苯基乙氧基)羰基)氨基)异噁唑-5-基)-[1,1’-联苯]-4-基)乙酸钠

CAS 1345614-59-6 MFCD445614596

化学结构图

1345614-59-6
SMILES:

化学属性

Mol. FormulaC27H24N2O5.Na

别名和识别编码

Chemical NameSodium (R)-2-(4’-(3-Methyl-4-(((1-Phenylethoxy)Carbonyl)Amino)Isoxazol-5-Yl)-[1,1’-Biphenyl]-4-Yl)Acetate
Chemical Name Translation(R)-2-(4’-(3-甲基-4-(((1-苯基乙氧基)羰基)氨基)异噁唑-5-基)-[1,1’-联苯]-4-基)乙酸钠
Chemicalbook IDCB52627312
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Castelino FV, et al. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum. 2011 May;63(5):1405-15.
  • [1]. Swaney JS, et al. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. J Pharmacol Exp Ther. 2011 Mar;336(3):693-700.
  • [1]. Swaney JS, et al. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. J Pharmacol Exp Ther. 2011 Mar;336(3):693-700.
  • [2]. Castelino FV, et al. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum. 2011 May;63(5):1405-15.

系列性分类

  1. Medical Research Areas
  2. GPCR & G Protein
  3. LPL Receptor  (溶血磷脂受体)

相关产品推荐